A cost-consequence model of using the 21-gene assay to identify patients with early-stage node-positive breast cancer who benefit from adjuvant chemotherapy in the Netherlands
Article in Journal of Medical Economics (March 2024)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Article in Journal of Medical Economics (March 2024)
Article in Journal of Surgical Research (February 2024)
Article in Cancers (October 2023)